Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04295447
Title Adjuvant Apalutamide in Subjects With High-risk Localized or Locally Advanced Prostate Cancer After Radical Prostatectomy (ADAM)
Acronym ADAM
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Westfalische Wilhelms-Universitat Munster
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU | AUT


No variant requirements are available.